{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:58:00Z","timestamp":1785560280771,"version":"3.56.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,8,1]]},"DOI":"10.2169\/internalmedicine.6576-25","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T22:07:50Z","timestamp":1766009270000},"page":"2024-2031","source":"Crossref","is-referenced-by-count":0,"title":["Association between Phosphate Binders and Constipation in Patients Undergoing Chronic Hemodialysis: A Cross-sectional Study"],"prefix":"10.2169","volume":"65","author":[{"given":"Mayuko","family":"Hori","sequence":"first","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Fujita Health University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Morozumi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 14: 82-99, 2007.","DOI":"10.1053\/j.ackd.2006.10.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sumida K, Yamagata K, Kovesdy CP. Constipation in CKD. Kidney Int Rep 5: 121-134, 2020.","DOI":"10.1016\/j.ekir.2019.11.002"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Sumida K, Molnar MZ, Potukuchi PK, et al. Constipation and risk of death and cardiovascular events. Atherosclerosis 281: 114-120, 2019.","DOI":"10.1016\/j.atherosclerosis.2018.12.021"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Salmoirago-Blotcher E, Crawford S, Jackson E, Ockene J, Ockene I. Constipation and risk of cardiovascular disease among postmenopausal women. Am J Med 124: 714-723, 2011.","DOI":"10.1016\/j.amjmed.2011.03.026"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Honda Y, Itano S, Kugimiya A, et al. Laxative use and mortality in patients on haemodialysis: a prospective cohort study. BMC Nephrol 22: 363, 2021.","DOI":"10.1186\/s12882-021-02572-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Biruete A, Hill Gallant KM, Lindemann SR, Wiese GN, Chen NX, Moe SM. Phosphate binders and nonphosphate effects in the gastrointestinal tract. J Ren Nutr 30: 4-10, 2020.","DOI":"10.1053\/j.jrn.2019.01.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fouque D, Vennegoor M, Ter Wee P, et al. EBPG guideline on nutrition. Nephrol Dial Transplant 22 Suppl 2: ii45-ii87, 2007.","DOI":"10.1093\/ndt\/gfm020"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lee A, Lambert K, Byrne P, Lonergan M. Prevalence of constipation in patients with advanced kidney disease. J Ren Care 42: 144-149, 2016.","DOI":"10.1111\/jorc.12157"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology 150: 1393-1470, 2016.","DOI":"10.1053\/j.gastro.2016.02.031"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Bharucha AE, Pemberton JH, Locke GR 3rd. American Gastroenterological Association technical review on constipation. Gastroenterology 144: 218-238, 2013.","DOI":"10.1053\/j.gastro.2012.10.028"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ikee R, Yano K, Tsuru T. Constipation in chronic kidney disease: it is time to reconsider. Ren Replace Ther 5: 51, 2019.","DOI":"10.1186\/s41100-019-0246-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hanafusa N, Abe M, Joki N, et al.; Japanese Society for Dialysis Therapy Renal Data Registry Committee. Annual dialysis data report 2019, JSDT renal data registry. Ren Replace Ther 9: 47, 2023.","DOI":"10.1186\/s41100-023-00478-z"},{"key":"13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.31083\/ph.2015.5573","volume":"70","author":"D Suzuki","year":"2015","unstructured":"13. Suzuki D, Ichie T, Hayashi H, Sugiura Y, Sugiyama T. Gastrointestinal symptoms after the substitution of sevelamer hydrochloride with lanthanum carbonate in Japanese patients undergoing hemodialysis. Pharmazie 70: 522-526, 2015.","journal-title":"Die Pharmazie","ISSN":"https:\/\/id.crossref.org\/issn\/0031-7144","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Miao YY, Xu CM, Xia M, Zhu HQ, Chen YQ. Relationship between gut microbiota and phosphorus metabolism in hemodialysis patients: a preliminary exploration. Chin Med J 131: 2792-2799, 2018.","DOI":"10.4103\/0366-6999.246059"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Effect of treating hyperphosphatemia with lanthanum carbonate vs calcium carbonate on cardiovascular events in patients with chronic kidney disease undergoing hemodialysis: the LANDMARK randomized clinical trial. JAMA 325: 1946-1954, 2021.","DOI":"10.1001\/jama.2021.4807"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Trautvetter U, Camarinha-Silva A, Jahreis G, Lorkowski S, Glei M. High phosphorus intake and gut-related parameters - results of a randomized placebo-controlled human intervention study. Nutr J 17: 23, 2018.","DOI":"10.1186\/s12937-018-0331-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wu PH, Liu PY, Chiu YW, et al. Comparative gut microbiome differences between ferric citrate and calcium carbonate phosphate binders in patients with end-stage kidney disease. Microorganisms 8: 2040, 2020.","DOI":"10.3390\/microorganisms8122040"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kortman GAM, Reijnders D, Swinkels DW. Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD. Hemodial Int 21 Suppl 1: S28-S36, 2017.","DOI":"10.1111\/hdi.12553"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Akizawa T, Origasa H, Kameoka C, Kaneko Y, Kawasaki S; Bixalomer Study Group. Randomized controlled trial of bixalomer versus sevelamer hydrochloride in hemodialysis patients with hyperphosphatemia. Ther Apher Dial 18: 122-131, 2014.","DOI":"10.1111\/1744-9987.12068"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hatakeyama S, Murasawa H, Narita T, et al. Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis. BMC Nephrol 14: 222, 2013.","DOI":"10.1186\/1471-2369-14-222"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31: 607-617, 1998.","DOI":"10.1053\/ajkd.1998.v31.pm9531176"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Habbous S, Przech S, Acedillo R, Sarma S, Garg AX, Martin J. The efficacy and safety of sevelamer and lanthanum versus calcium containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant 32: 111-125, 2017.","DOI":"10.1093\/ndt\/gfw312"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/15\/65_6576-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:13:39Z","timestamp":1785557619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/15\/65_6576-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":22,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6576-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"article-number":"6576-25"}}